Abeona Therapeutics earnings were -$62.5M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest ABEO earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$4.8M, down 76.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ABEO reported annual earnings of $71.2M, with -211.7% growth.
Abeona Therapeutics Earnings Reports & History FAQ
What were Abeona Therapeutics's earnings last quarter?
On ABEO's earnings call on Nov 9, 2026, Abeona Therapeutics (NASDAQ: ABEO) reported Q3 2026 earnings per share (EPS) of -$0.08, up 20% year over year. Total ABEO earnings for the quarter were -$4.81 million. In the same quarter last year, Abeona Therapeutics's earnings per share (EPS) was -$0.10.
Is Abeona Therapeutics profitable or losing money?
As of the last Abeona Therapeutics earnings report, Abeona Therapeutics is currently losing money. Abeona Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$62.53 million, a 175.94% decrease year over year.
What was ABEO's earnings growth in the past year?
As of Abeona Therapeutics's earnings date in Nov 9, 2026, Abeona Therapeutics's earnings has grown year over year. ABEO earnings in the past year totalled -$62.53 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.